Guest Speakers

Presented by Robert G. Stern, MD.

Several prescription drugs have been available to treat the symptoms of Alzheimer’s disease for many years. In the past 2 years, the U.S. Food and Drug Administration (FDA) has given full approval to disease-modifying drugs. These medications are called disease-modifying drugs because they work by targeting and clearing beta-amyloid plaques from the brain.

Join Alzheimer’s New Jersey along with Tess Tomasi, I&A/Care Management Supervisor, Bergen County Division of Senior Services, and Colleen Smith, LCSW Caregiver Specialist, Monmouth County Office on Aging, to learn about the role of the Office on Aging and resources available statewide. These include programs related to home safety and respite from caregiving as well as financial assistance.